Semi-Annual Balance Sheet

Medrx Co.,Ltd. - Filing #7339301

Concept As at
2024-03-31
As at
2023-12-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,623,163,000 JPY
1,720,720,000 JPY
Other
19,439,000 JPY
10,440,000 JPY
Current assets
1,665,575,000 JPY
1,785,015,000 JPY
Accounts receivable - other
4,586,000 JPY
33,020,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
170,703,000 JPY
181,547,000 JPY
Tools, furniture and fixtures
Tools, furniture and fixtures, net
2,193,000 JPY
2,298,000 JPY
Investments and other assets
Investments and other assets
85,237,000 JPY
85,690,000 JPY
Distressed receivables
2,288,000 JPY
2,288,000 JPY
Long-term prepaid expenses
45,261,000 JPY
45,714,000 JPY
Other
1,549,000 JPY
1,549,000 JPY
Allowance for doubtful accounts
-2,288,000 JPY
-2,288,000 JPY
Non-current assets
255,941,000 JPY
267,237,000 JPY
Assets
1,921,517,000 JPY
2,052,252,000 JPY
Liabilities
Current liabilities
Income taxes payable
3,131,000 JPY
7,661,000 JPY
Other
3,569,000 JPY
1,485,000 JPY
Current liabilities
37,999,000 JPY
99,993,000 JPY
Accounts payable - other
31,298,000 JPY
90,846,000 JPY
Non-current liabilities
Non-current liabilities
27,556,000 JPY
27,527,000 JPY
Asset retirement obligations
22,674,000 JPY
22,609,000 JPY
Liabilities
65,555,000 JPY
127,520,000 JPY
Other liabilities
Deferred tax liabilities
4,882,000 JPY
4,918,000 JPY
Other liabilities
Net assets
Share capital
876,352,000 JPY
847,504,000 JPY
Shareholders' equity
Capital surplus
Capital surplus
1,944,946,000 JPY
1,916,098,000 JPY
Retained earnings
Retained earnings
-1,043,998,000 JPY
-915,728,000 JPY
Treasury shares
0 JPY
0 JPY
Shareholders' equity
1,777,300,000 JPY
1,847,874,000 JPY
Valuation and translation adjustments
Valuation and translation adjustments
8,357,000 JPY
10,500,000 JPY
Net assets
1,855,961,000 JPY
1,924,731,000 JPY
Share acquisition rights
70,303,000 JPY
66,357,000 JPY
Liabilities and net assets
1,921,517,000 JPY
2,052,252,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.